CST

Humphreys & Partners Architects to Host Student Housing Webinar

Retrieved on: 
Tuesday, March 21, 2023
Student, Humphreys and Partners Architects, Retirement, Housing, Real estate, Senior, HPA, Humphreys, CST, Walker & Dunlop, Partner, Management

DALLAS, March 21, 2023 /PRNewswire/ -- Prominent Dallas architecture firm, Humphreys & Partners Architects (HPA), will host a student housing webinar on Tuesday, March 28, 2023, at 2:00 p.m. CST. A panel of seasoned experts will take a deep dive into key issues impacting the student housing market including construction costs, design shifts, projected rental pricing, conventional student lending, demographic changes, and the latest trends in the student housing sector.

Key Points: 
  • DALLAS, March 21, 2023 /PRNewswire/ -- Prominent Dallas architecture firm, Humphreys & Partners Architects (HPA), will host a student housing webinar on Tuesday, March 28, 2023, at 2:00 p.m. CST.
  • A panel of seasoned experts will take a deep dive into key issues impacting the student housing market including construction costs, design shifts, projected rental pricing, conventional student lending, demographic changes, and the latest trends in the student housing sector.
  • "Year-over-year the demand for student housing continues to increase on campuses across the country," stated Greg Faulkner.
  • To learn more about Humphreys & Partners and their award-winning student housing designs, visit humphreys.com .

QurAlis Reveals Newest Program Targeting UNC13A RNA Mis-splicing Incorporating its FlexASO™ Platform

Retrieved on: 
Monday, March 20, 2023
Asos, DNA, FRCP, Gene, Therapeutic index, Episcopal conference, RNA, Gene therapy, Cytoplasm, HIV disease progression rates, Patient, Muscular Dystrophy Association, CST, Frontotemporal dementia, Synapse, ASO, MDA, ALS, FTD, Disease, Vaccine, UNC13A

CAMBRIDGE, Mass., March 20, 2023 /PRNewswire/ -- QurAlis Corporation, a clinical-stage biotechnology company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced the launch of its newest program that targets UNC13A mis-splicing, a critical genetic alteration in neurodegenerative diseases like ALS and frontotemporal dementia (FTD). Incorporating its proprietary FlexASO™ Splice Modulator Platform, QurAlis' antisense oligonucleotides (ASOs) correct this mis-splicing, restore UNC13A protein production, and reduce cryptic exons that may contribute to disease progression. An exon is a segment of a DNA or RNA molecule containing information coding for a protein or peptide sequence.

Key Points: 
  • Incorporating its proprietary FlexASO™ Splice Modulator Platform, QurAlis' antisense oligonucleotides (ASOs) correct this mis-splicing, restore UNC13A protein production, and reduce cryptic exons that may contribute to disease progression.
  • An exon is a segment of a DNA or RNA molecule containing information coding for a protein or peptide sequence.
  • "We are excited to bring our UNC13A program out of stealth.
  • UNC13A is the third QurAlis program focused on a genetic target for the development of much-needed precision medicines for the sporadic ALS and FTD populations," said Kasper Roet, Ph.D., chief executive officer of QurAlis.

Voluntary Recall of One Lot of Kaytee® Wild Bird Food Birders’ Blend, 8 Lb. Bag, Due to Elevated Levels of Aflatoxin

Retrieved on: 
Saturday, March 18, 2023
Family, Retail, Other Consumer, Consumer, Seniors, Specialty, Pets, Food, CST, Regulation of tobacco by the U.S. Food and Drug Administration, Southeastern United States, GA, Safety

The affected wild bird product was packaged in clear plastic bags and shipped to ACE Hardware Distribution Centers in AL, FL, and GA, which service neighborhood hardware stores in the Southeastern United States.

Key Points: 
  • The affected wild bird product was packaged in clear plastic bags and shipped to ACE Hardware Distribution Centers in AL, FL, and GA, which service neighborhood hardware stores in the Southeastern United States.
  • Retailers who received the affected wild bird product have been contacted and asked to pull them from their inventory and shelves.
  • No adverse health effects have been reported with respect to the affected wild bird product at this time.
  • Consumers who have purchased the recalled wild bird product should return it to the place of purchase for a full refund.

Claremont School of Theology Announces Relocation to Los Angeles

Retrieved on: 
Wednesday, March 15, 2023
Multimedia, COVID, UCLA, Heart, University, Methodism, School, Partnership, Life, Mentorship, Westwood United Methodist Church, Teaching, Housing, Willamette University, Maintenance, Compassion, TCC, Faculty, Student, CST, Claremont School of Theology, University of Southern California, Claremont Colleges, Justice, University of California, Walking, Fashion design, Nursing, Management, Trustee, Belonging, USC, United Methodist Church, Theology

CLAREMONT, Calif., March 15, 2023 /PRNewswire/ -- Claremont School of Theology (CST) announced today that for the first time in 66 years it will be relocating this summer to Los Angeles, CA.

Key Points: 
  • CLAREMONT, Calif., March 15, 2023 /PRNewswire/ -- Claremont School of Theology (CST) announced today that for the first time in 66 years it will be relocating this summer to Los Angeles, CA.
  • The name of the school will remain Claremont School of Theology.
  • Claremont School of Theology is currently in a final review and affirmation process with WSCUC of the Westwood location.
  • Claremont School of Theology is United Methodist in origin and affiliation and ecumenical and interreligious in spirit.

4D Molecular Therapeutics Reports Full Year 2022 Financial Results and Operational Highlights

Retrieved on: 
Wednesday, March 15, 2023
DME, EMA, Roche, Conference, Cystic fibrosis, Annual general meeting, VG, D, Macular degeneration, Diabetic retinopathy, Risk, PRISM, Fabry, Cohort, GMP, ARVO, Security (finance), CMC, Fabry disease, Patient, Cash, Research, FDA, AMD, CST, Safety, Clinical trial, IND, Vaccine, Pharmaceutical industry, 3D printing, Cryptocurrency, Ophthalmology

Our five clinical-stage product candidates address unmet medical needs in seven patient populations, including several large and high incidence rate disease markets.

Key Points: 
  • Our five clinical-stage product candidates address unmet medical needs in seven patient populations, including several large and high incidence rate disease markets.
  • R&D Expenses: Research and development expenses were $80.3 million for 2022, as compared to $61.4 million for 2021.
  • G&A Expenses: General and administrative expenses were $32.9 million for 2022, as compared to $28.0 million for 2021.
  • Net Loss: Net loss was $107.5 million for 2022, as compared to $71.3 million for 2021.

Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema and Announces Board Changes

Retrieved on: 
Tuesday, March 14, 2023
CFO, Education, Sarbanes–Oxley Act, Prevalence, Tel Aviv Sourasky Medical Center, IDMC, Month, Plasma kallikrein, System, Eye, Caregiver burden, Macula, Diabetic retinopathy, Human, University, Brussels Stock Exchange, Retina, MBA, CFA, KKS, CET, Diabetes, Part, MD, Patient, Medicare Part D, Inflammation, Tel Aviv University, CST, Safety, Injection, Optical coherence tomography, DME, Blurry, Paratriathlon, Pharmaceutical industry, Medical device, Management, Nursing, Vaccine, Ophthalmology

The KALAHARI trial is evaluating Oxurion’s novel plasma kallikrein (PKal) inhibitor THR-149 as a potential treatment for patients with diabetic macular edema (DME) who respond suboptimally to anti-VEGF therapy, the current standard of care.

Key Points: 
  • The KALAHARI trial is evaluating Oxurion’s novel plasma kallikrein (PKal) inhibitor THR-149 as a potential treatment for patients with diabetic macular edema (DME) who respond suboptimally to anti-VEGF therapy, the current standard of care.
  • The Phase 2 KALAHARI trial is a two-part, randomized, prospective, multi-center trial assessing multiple (3) injections of THR-149 in DME patients.
  • Part B is double-masked and actively controlled, with the high dose of THR-149 having been selected from Part A of the trial.
  • The Month 6 data also demonstrated THR-149’s attractive safety profile and its ability to stabilize the Central Subfield Thickness (CST).

NextGen Healthcare to Highlight Interoperability and Health Equity at Top Healthcare Technology Events

Retrieved on: 
Wednesday, March 15, 2023
Software, Practice Management, Telemedicine, Virtual Medicine, Managed Care, Health, Data Management, Health Technology, Technology, Booth, NextGen Healthcare, University of Toledo, Patient, ViVe, Health equity, Venice Family Clinic, Snowflake, EHR, HIMSS, CST, University, Digital technology, Pharmaceutical industry, Asset management, United States Department of Agriculture South Building

NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its participation in two industry-leading healthcare technology conferences, ViVE 2023 and HIMSS 23.

Key Points: 
  • NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced its participation in two industry-leading healthcare technology conferences, ViVE 2023 and HIMSS 23.
  • The company will showcase how it enables interoperability and health equity across the industry in speaker sessions and booth demonstrations at both events.
  • NextGen Healthcare is a premiere sponsor of the InteropNOW!
  • NextGen Healthcare clients Venice Family Clinic and Neighborhood Health will participate in the discussion, which was also selected to be included in the HIMSS Health Equity Series .

NorthStar Emergency Medical Services - Notice of Data Security Incident

Retrieved on: 
Tuesday, March 14, 2023
Social, Name, NorthStar, Social Security, Environment, CST, AL, Patient, Centers for Medicare & Medicaid Services, Pharmaceutical industry

TUSCALOOSA, Ala., March 14, 2023 /PRNewswire/ -- NorthStar Emergency Medical Services ("NorthStar") has learned of a data security incident that may have impacted data belonging to certain current and former patients.

Key Points: 
  • TUSCALOOSA, Ala., March 14, 2023 /PRNewswire/ -- NorthStar Emergency Medical Services ("NorthStar") has learned of a data security incident that may have impacted data belonging to certain current and former patients.
  • As a result of the investigation, NorthStar learned that an unauthorized actor accessed certain data stored on its network.
  • NorthStar then undertook an in-depth and time-consuming review of the data in order to determine whether any personal or protected health information was affected by the incident.
  • On March 14, 2023, NorthStar provided written notification of the incident via US mail to impacted individuals.

GORDON FOOD SERVICE ANNOUNCES TEXAS EXPANSION WITH SIX NEW HOUSTON AREA STORES

Retrieved on: 
Monday, March 13, 2023
Cookout, Local, Rib, Wholesaling, CST, Champion, Gordon Food Service, Department store

HOUSTON, March 13, 2023 /PRNewswire/ -- Gordon Food Service®, a privately held and family-managed foodservice distributor with operations in the U.S. and Canada, today announced it will open six new Gordon Food Service Stores in the greater Houston area to serve local restaurants, food operations and the public. The new Gordon Food Service Stores are the first Texas locations and the most opened by the company at one time.

Key Points: 
  • HOUSTON, March 13, 2023 /PRNewswire/ -- Gordon Food Service® , a privately held and family-managed foodservice distributor with operations in the U.S. and Canada, today announced it will open six new Gordon Food Service Stores in the greater Houston area to serve local restaurants, food operations and the public.
  • The new Gordon Food Service Stores are the first Texas locations and the most opened by the company at one time.
  • Gordon Food Service Stores opening March 14:
    Houston - FM 1960 W, located at Champions, FM 1960 at Stuebner Airline
    "Gordon Food Service Store believes in the power of good food and its ability to bring people together and make moments special," said Tim Grabar, president, Gordon Food Service Stores.
  • "We are excited to open our doors to the greater Houston community and provide the chef-quality food products our stores are known for."

DallasNews Corporation Announces Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Thursday, March 9, 2023
Advertising, CST, IP, DallasNews Corporation, Webcast, Return, Digital, CDT, GAAP, Depreciation, Marketing, Sale, Total, Video game, Cryptocurrency, Insurance, Publishing, Pharmaceutical industry

DALLAS, March 09, 2023 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) today reported a fourth quarter 2022 net loss of $2.1 million, or $(0.40) per share, and an operating loss of $1.9 million.

Key Points: 
  • DALLAS, March 09, 2023 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) today reported a fourth quarter 2022 net loss of $2.1 million, or $(0.40) per share, and an operating loss of $1.9 million.
  • Circulation revenue was $16.6 million in the fourth quarter of 2022, a decrease of less than $0.1 million when compared to the fourth quarter of 2021.
  • Total consolidated operating expense in the fourth quarter of 2022, on a GAAP basis, was $41.0 million, an improvement of $0.2 million or 0.5 percent when compared to the fourth quarter of 2021.
  • DallasNews Corporation will conduct a conference call on Friday, March 10, 2023, at 9:00 a.m. CST to discuss financial results.